DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/14986
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJadhav, Hemant R.-
dc.date.accessioned2024-05-24T09:06:08Z-
dc.date.available2024-05-24T09:06:08Z-
dc.date.issued2023-10-
dc.identifier.urihttps://www.eurekaselect.com/article/135622-
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/14986-
dc.description.abstractCancer is one of the significant healthcare challenges in today’s world, even after advancements in modern science, including oncology. The complex nature of the disease, which involves multiple proteins and pathways, poses a substantial challenge in drug discovery. Several therapeutic options have emerged in the last decade. Systemic cancer therapies began with the advent of chemotherapy and were revolutionized with the development of targeted therapies. The present review is a definite overview of the advances in various therapeutic options for cancer, with a particular emphasis on targeted therapy using small molecules and biologicalsen_US
dc.language.isoenen_US
dc.publisherBentham Scienceen_US
dc.subjectPharmacyen_US
dc.subjectAnti-cancer therapeuticsen_US
dc.subjectTargeted therapyen_US
dc.subjectKinase inhibitorsen_US
dc.subjectMonoclonal antibodiesen_US
dc.subjectOncologyen_US
dc.subjectCancer treatmenten_US
dc.titleA Comprehensive Review of Systemic Targeted Therapies in Cancer Treatmenten_US
dc.typeArticleen_US
Appears in Collections:Department of Pharmacy

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.